Company Overview of Xantech Pharmaceuticals Inc.
Xantech Pharmaceuticals Inc., a wholly owned subsidiary of Provectus Pharmaceuticals Inc., develops prescription drugs for dermatology and oncology, medical and research laser technologies, and biotechnology. The drugs are used in treatment of skin afflictions, cancers, chronic diseases, and tumors and vaccine production. Xantech is based in Knoxville, Tennessee.
7327 Oak Ridge Highway
Knoxville, TN 37931
Key Executives for Xantech Pharmaceuticals Inc.
Xantech Pharmaceuticals Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3Bar Biologics Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Xantech Pharmaceuticals Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.